Ostergren-Lundén G - Search Results

1

Binding of platelet-derived growth factor and low density lipoproteins to glycosaminoglycan species produced by human arterial smooth muscle cells.

Fager G, Camejo G, Olsson U, Ostergren-Lundén G, Lustig F, Bondjers G. Fager G, et al. J Cell Physiol. 1995 May;163(2):380-92. doi: 10.1002/jcp.1041630218. J Cell Physiol. 1995. PMID: 7706380

2

Fatty acids cause alterations of human arterial smooth muscle cell proteoglycans that increase the affinity for low-density lipoprotein.

Rodríguez-Lee M, Ostergren-Lundén G, Wallin B, Moses J, Bondjers G, Camejo G. Rodríguez-Lee M, et al. Among authors: ostergren lunden g. Arterioscler Thromb Vasc Biol. 2006 Jan;26(1):130-5. doi: 10.1161/01.ATV.0000191659.94059.62. Epub 2005 Oct 20. Arterioscler Thromb Vasc Biol. 2006. PMID: 16239593

3

Characterisation and application of antibodies specific for the long platelet-derived growth factor A and B chains.

Ostergren-Lundén G, Olivas RG, Eftekhari P, Krettek A, Sanjuan X, Fager G, Vilaró S, Lustig F, Hoebeke J. Ostergren-Lundén G, et al. Int J Biochem Cell Biol. 2004 Nov;36(11):2226-41. doi: 10.1016/j.biocel.2004.05.001. Int J Biochem Cell Biol. 2004. PMID: 15313468

4

Heparin-like glycosaminoglycans influence growth and phenotype of human arterial smooth muscle cells in vitro. II. The platelet-derived growth factor A-chain contains a sequence that specifically binds heparin.

Fager G, Camejo G, Olsson U, Ostergren-Lundén G, Bondjers G. Fager G, et al. In Vitro Cell Dev Biol. 1992 Mar;28A(3 Pt 1):176-80. doi: 10.1007/BF02631088. In Vitro Cell Dev Biol. 1992. PMID: 1582992

5

Alternative splicing determines the binding of platelet-derived growth factor (PDGF-AA) to glycosaminoglycans.

Lustig F, Hoebeke J, Ostergren-Lundèn G, Velge-Roussel F, Bondjers G, Olsson U, Rüetschi U, Fager G. Lustig F, et al. Biochemistry. 1996 Sep 17;35(37):12077-85. doi: 10.1021/bi960118l. Biochemistry. 1996. PMID: 8810913

6

Quantitation of platelet-derived growth factor receptors in human arterial smooth muscle cells in vitro.

Krettek A, Fager G, Jernberg P, Ostergren-Lundén G, Lustig F. Krettek A, et al. Among authors: ostergren lunden g. Arterioscler Thromb Vasc Biol. 1997 Nov;17(11):2395-404. doi: 10.1161/01.atv.17.11.2395. Arterioscler Thromb Vasc Biol. 1997. PMID: 9409207

7

Glycosaminoglycan-lipoprotein interaction.

Olsson U, Ostergren-Lundén G, Moses J. Olsson U, et al. Among authors: ostergren lunden g. Glycoconj J. 2001 Oct;18(10):789-97. doi: 10.1023/a:1021155518464. Glycoconj J. 2001. PMID: 12441668

8

IFNgamma regulates PDGF-receptor alpha expression in macrophages, THP-1 cells, and arterial smooth muscle cells.

Morelli PI, Martinsson S, Ostergren-Lundén G, Fridén V, Moses J, Bondjers G, Krettek A, Lustig F. Morelli PI, et al. Among authors: ostergren lunden g. Atherosclerosis. 2006 Jan;184(1):39-47. doi: 10.1016/j.atherosclerosis.2005.03.026. Atherosclerosis. 2006. PMID: 15871904

9

Hypoxia increases macrophage motility, possibly by decreasing the heparan sulfate proteoglycan biosynthesis.

Asplund A, Ostergren-Lundén G, Camejo G, Stillemark-Billton P, Bondjers G. Asplund A, et al. Among authors: ostergren lunden g. J Leukoc Biol. 2009 Aug;86(2):381-8. doi: 10.1189/jlb.0908536. Epub 2009 Apr 28. J Leukoc Biol. 2009. PMID: 19401393

10

Processing of PDGF gene products determines interactions with glycosaminoglycans.

Lustig F, Hoebeke J, Simonson C, Ostergren-Lundén G, Bondjers G, Rüetchi U, Fager G. Lustig F, et al. Among authors: ostergren lunden g. J Mol Recognit. 1999 Mar-Apr;12(2):112-20. doi: 10.1002/(SICI)1099-1352(199903/04)12:2<112::AID-JMR452>3.0.CO;2-R. J Mol Recognit. 1999. PMID: 10398402

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

13 results

Search Page